Skip to main content
. 2011 Feb 18;32(6):1617–1624. doi: 10.1007/s00296-011-1807-0

Fig. 2.

Fig. 2

Incidence rate of serious adverse events by dose of MTX. IFX infliximab; MTX methotrexate. *P < 0.05 for all doses versus 0 mg MTX (Fisher’s exact test). Values in parentheses indicate number of subjects per group